Inhibitor Therapeutics, Inc. Current Assets
Inhibitor Therapeutics, Inc. (INTI) had Current Assets of $586.81 thousand as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2026-08-14
- 2026-06-30: Assets, Current $586.81K.
- 2026-03-31: Assets, Current $1.38M.
- 2025-12-31: Assets, Current $2.45M.
- 2025-09-30: Assets, Current $3.06M.
| Period end | Assets, Current |
|---|---|
| 2026-06-30 | $586.81K 10-Q · filed 2026-08-14 |
| 2026-03-31 | $1.38M 10-Q · filed 2026-05-15 |
| 2025-12-31 | $2.45M 10-Q · filed 2026-08-14 |
| 2025-09-30 | $3.06M 10-Q · filed 2025-11-13 |
| 2025-06-30 | $3.83M 10-Q · filed 2025-08-13 |
| 2025-03-31 | $4.42M 10-Q · filed 2025-05-14 |
| 2024-12-31 | $5.69M 10-K · filed 2026-03-26 |
| 2024-09-30 | $6.45M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $7.17M 10-Q · filed 2024-08-06 |
| 2024-03-31 | $7.79M 10-Q · filed 2024-05-13 |
| 2023-12-31 | $8.95M 10-K · filed 2025-03-28 |
| 2023-09-30 | $9.61M 10-Q · filed 2023-11-13 |
| 2023-06-30 | $10.16M 10-Q · filed 2023-08-11 |
| 2023-03-31 | $10.84M 10-Q · filed 2023-05-15 |
| 2022-12-31 | $11.98M 10-K · filed 2024-03-29 |
| 2022-09-30 | $63.12K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $38.52K 10-Q · filed 2022-08-12 |
| 2022-03-31 | $61.14K 10-Q · filed 2022-05-13 |
| 2021-12-31 | $58.78K 10-K · filed 2023-03-31 |
| 2021-09-30 | $90.08K 10-Q · filed 2021-11-12 |
| 2021-06-30 | $126.76K 10-Q · filed 2021-08-13 |
| 2021-03-31 | $120.98K 10-Q · filed 2021-05-14 |
| 2020-12-31 | $107.35K 10-K · filed 2022-03-30 |
| 2020-09-30 | $72.00K 10-Q · filed 2020-11-16 |
| 2020-06-30 | $177.35K 10-Q · filed 2020-08-12 |
| 2020-03-31 | $350.93K 10-Q · filed 2020-05-01 |
| 2019-12-31 | $846.27K 10-K · filed 2021-03-26 |
| 2019-09-30 | $1.42M 10-Q · filed 2019-11-07 |
| 2019-06-30 | $2.06M 10-Q · filed 2019-08-12 |
| 2019-03-31 | $1.18M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $1.15M 10-K · filed 2020-03-30 |
| 2018-09-30 | $1.74M 10-Q · filed 2018-11-14 |
| 2018-06-30 | $1.09M 10-Q · filed 2018-07-23 |
| 2018-03-31 | $1.87M 10-Q · filed 2018-05-01 |
| 2017-12-31 | $655.77K 10-K · filed 2019-03-07 |
| 2017-09-30 | $1.19M 10-Q · filed 2017-10-31 |
| 2017-06-30 | $1.93M 10-Q · filed 2017-07-31 |
| 2017-03-31 | $2.64M 10-Q · filed 2017-05-08 |
| 2016-12-31 | $7.20M 10-K · filed 2018-02-16 |
| 2016-09-30 | $3.61M 10-Q · filed 2016-10-31 |
| 2016-06-30 | $4.67M 10-Q · filed 2016-08-12 |
| 2016-03-31 | $170.64K 10-Q · filed 2016-05-13 |
| 2015-12-31 | $635.86K 10-K · filed 2017-02-17 |
| 2015-09-30 | $1.30M 10-Q · filed 2015-11-04 |
| 2015-06-30 | $1.94M 10-Q · filed 2015-08-14 |
| 2015-03-31 | $127.67K 10-Q · filed 2015-05-13 |
| 2014-12-31 | $462.98K 10-K · filed 2016-02-01 |
| 2014-09-30 | $423.11K 10-Q · filed 2014-10-10 |
| 2014-06-30 | $300.52K 10-Q · filed 2014-08-13 |
| 2014-03-31 | $10.46K 10-Q · filed 2014-05-12 |
| 2013-12-31 | $10.22K 10-K · filed 2015-02-13 |
| 2013-09-30 | $112.00 10-Q · filed 2013-11-14 |
| 2012-12-31 | $936.43K 10-K · filed 2014-04-15 |